4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-010606
SVP, Chief Technical Officer sold 12,000 shares at $30.43 ($365,148)
From the SEC's structured data for this filing
Trades in this filing
LaBarre Michael J. · SVP, Chief Technical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-20 | Sale : show line 1 in the form | −12,000 | $30.43 | $365,148 | 146,800 | D |
| Open-market sales · 12,000 sh · avg $30.43 · $365,148 | ||||||
Loading xslF345X03/edgar.xml…